Influence of the use of statin on the stability of erythrocyte membranes in multiple sclerosis

Journal of Membrane Biology

Volumn 233, Issue 1-3, 2010, Pages 127-134

  De Freitas, Mariana Vaini ^a   De Oliveira, Marcela Ramos ^a   Dos Santos, Diogo Fernandes ^a   De Cássia Mascarenhas Netto, Rita ^a   Fenelon, Sheila Bernardino ^a   Penha Silva, Nilson ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

Author keywords

Cholesterol; Erythrocyte; Hemolysis; Membrane; Multiple sclerosis; Stability; Statin

Indexed keywords

ALCOHOL; SIMVASTATIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ERYTHROCYTE FRAGILITY; ERYTHROCYTE MEMBRANE; FEMALE; HEMOLYSIS; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOOSMOTIC STRESS; MEMBRANE STABILIZATION; MULTIPLE SCLEROSIS;

ADULT; CENTRAL NERVOUS SYSTEM DEPRESSANTS; ERYTHROCYTE MEMBRANE; ETHANOL; FEMALE; HEMOLYSIS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MIDDLE AGED; MULTIPLE SCLEROSIS; SIMVASTATIN;

EID: 77649233286     PISSN: 00222631     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00232-010-9232-y     Document Type: Article

References (64)

1. JJ Alberts SM Marcovina RH Christensen 1992 Lecithin cholesterol acyltransferase in human cerebrospinal fluid: reduced level in patients with multiple sclerosis and evidence of direct synthesis in the brain Int J Clin Lab Res 22 169 172 10.1007/BF02591418
2. M Aviram M Rosenblat CL Bisgaier RS Newton 1998 Atorvastatin and gemfibrozil metabolites, but not the parent drugs are potent antioxidants against lipoprotein oxidation Atherosclerosis 138 271 280 10.1016/S0021-9150(98) 00032-X 1:CAS:528:DyaK1cXksFyjt70%3D 9690910 (Pubitemid 28314098)
3. HT Besler S Comoglu 2003 Lipoprotein oxidation, plasma total antioxidant capacity and homocysteine level in patients with multiple sclerosis Nutr Neurosci 6 189 196 10.1080/1028415031000115945 1:CAS:528:DC%2BD3sXktVGlt7c%3D 12793524 (Pubitemid 36656698)
4. PC Calder 2005 Polyunsaturated fatty acids and inflammation Biochem Soc Trans 33 423 427 10.1042/BST0330423 1:CAS:528:DC%2BD2MXivFWjtro%3D 15787620 (Pubitemid 40604386)
5. EA Caspary F Sewell EJ Field 1967 Red blood cell fragility in multiple sclerosis BMJ 2 610 611 10.1136/bmj.2.5552.610 1:STN:280:DyaF2s7mt1enuw%3D%3D 6025599
6. A Chabanel M Flamm KL Sung MM Lee SL Schachter S Chien 1983 Influence of cholesterol content on red cell membrane viscoelasticity and fluidity Biophys J 44 171 176 10.1016/S0006-3495(83)84288-X 1:CAS:528:DyaL3sXmtFSntL8%3D 6652212
7. GD Cherayil 1990 Effects of in vitro hyperthermia on fatty acids of red blood cells and plasma lipids from patients with multiple sclerosis J Neurol Sci 95 141 151 10.1016/0022-510X(90)90237-H 1:CAS:528:DyaK3cXksFKkur0%3D 2324765 (Pubitemid 20061703)
8. R Coccia C Spadaccio C Foppoli M Perluigi E Covino M Lusini M Chello 2007 The effect of simvastatin on erythrocyte membrane fluidity during oxidative stress induced by cardiopulmonary bypass: a randomized controlled study Clin Ther 29 1706 1717 10.1016/j.clinthera.2007.08.010 1:CAS:528:DC%2BD2sXhtFyjt7nM 17919551 (Pubitemid 47494546)
9. S Comoglu S Yardimci Z Okcu 2004 Body fat distribution and plasma lipid profiles of patients with multiple sclerosis Turk J Med Sci 34 43 48
10. RA Cooper 1977 Abnormalities of cell-membrane fluidity in pathogenesis of disease N Engl J Med 297 371 377 1:CAS:528:DyaE2sXltlWls7Y%3D 327326
11. RA Cooper EC Arner JS Wiley JS Shattil 1975 Modifications of red cell membrane structure by cholesterol-rich lipid dispersion J Clin Invest 55 115 125 10.1172/JCI107901 1:CAS:528:DyaE2MXlsFKrtw%3D%3D 162782
12. A Corsini S Bellosta R Baetta R Fumagalli R Paoletti F Bernini 1999 New insights into the pharmacodynamic and pharmacokinetic properties of statins Pharmacol Ther 84 413 428 10.1016/S0163-7258(99)00045-5 1:CAS:528: DyaK1MXnslGqs78%3D 10665838
13. S Cribier G Morrot A Zachowski 1993 Dynamics of the membrane lipid phase Prostaglandins Leukot Essent Fatty Acids 48 24 32 10.1016/0952-3278(93)90006-I (Pubitemid 23011110)
14. CC Cunha LR Arvelos JO Costa N Penha-Silva 2007 Effects of glycerol on the thermal dependence of the stability of human erythrocytes J Bioenerg Biomembr 39 341 347 10.1007/s10863-007-9092-z 1:CAS:528:DC%2BD2sXhtl2ju7nE 17917799 (Pubitemid 350029430)
15. SC Cunnane SY Ho P Dore-Duffy KR Ells DF Horrobin 1989 Essential fatty acid and lipid profiles in plasma and erythrocytes in patients with multiple sclerosis Am J Clin Nutr 50 801 806 1:STN:280:DyaK3c%2Fitlejuw%3D%3D 2801584
16. MV De Freitas RCM Netto JCC Huss TMT De Souza JO Costa CB Firmino N Penha-Silva 2008 Influence of aqueous crude extracts of medicinal plants on the osmotic stability of human erythrocytes Toxicol In Vitro 22 219 224 10.1016/j.tiv.2007.07.010 17855047 (Pubitemid 350267105)
17. JF Dwight AC Mendes-Ribeiro BM Hendry 1996 Effects of HMG-CoA reductase inhibition on erythrocyte membrane cholesterol and acyl chain composition Clin Chim Acta 256 53 63 10.1016/S0009-8981(96)06412-1 1:STN:280:DyaK2s7itVWitA%3D%3D 8960787 (Pubitemid 26405110)
18. LC Fonseca NCR Corrêa MS Garrote-Filho CC Cunha N Penha-Silva 2006 Effects of the solvent composition on the stability of proteins in aqueous solutions Quim Nova 29 543 548 1:CAS:528:DC%2BD28XltVCgs74%3D
19. EM Frohman MK Racke CS Raine 2006 Multiple sclerosis-the plaque and its pathogenesis N Engl J Med 354 942 955 10.1056/NEJMra052130 1:CAS:528: DC%2BD28XitVertLc%3D 16510748 (Pubitemid 43313661)
20. A Glabinski NS Tawsek G Bartosz 1993 Increased generation of superoxide radicals in the blood of MS patients Acta Neurol Scand 88 174 177 10.1111/j.1600-0447.1993.tb03434.x 1:STN:280:DyaK2c%2FnvVOjtw%3D%3D 8256552
21. MG Grasso A Colleluori E Millefiorini C Pozzilli 1992 Lack of association between macrocytosis and multiple sclerosis J Neurol Neurosurg Psychiatry 55 1096 1097 10.1136/jnnp.55.11.1096 1:STN:280:DyaK3s7gsl2ksQ%3D%3D 1469411
22. Hauser SL, Goodkin DE (1998) Multiple sclerosis and other demyelinating diseases. In: Fauci AS, Braunwald E, Isselbacher KJ, Wilson DJ, Martin JB, Kasper DL, Longo SL (eds) Harrison's principles of internal medicine, 14 edn. McGraw-Hill, New York, pp 2452-2461
23. LJ Herrinton GD Friedman 1995 Serum cholesterol concentration and risk of brain cancer BMJ 310 367 368 1:STN:280:DyaK2M7ntVGisQ%3D%3D 7866214
24. NC Jain 1973 Osmotic fragility of erythrocytes of dogs and cats in health and in certain hematologic disorders Cornell Vet 63 411 423 1:STN:280:DyaE2c7hsFShsA%3D%3D 4782558
25. JA Joseph N Denisova D Fisher P Bickford R Prior G Cao 1998 Age-related neurodegeneration and oxidative stress: putative nutritional intervention Neurol Clin 16 747 755 10.1016/S0733-8619(05)70092-X 1:STN:280:DyaK1czjt1Olug%3D%3D 9666048 (Pubitemid 28408984)
26. S Knight 1977 Cellular immunity in multiple sclerosis Br Med Bull 33 45 50 1:STN:280:DyaE2s%2FovVGgsg%3D%3D 137763
27. M Koch GSM Ramsarannsing MR Fokkema DJ Heersema JD Keyser 2006 Erythrocyte membrane fatty acids in benign and progressive forms of multiple sclerosis J Neurol Sci 244 123 126 10.1016/j.jns.2006.01.010 1:CAS:528:DC%2BD28XjvVGmtLc%3D 16519904
28. M Kopff I Zakrzewska J Czernicki J Klem M Strzelczyk 1993 Red blood cell adenosine deaminase activity in multiple sclerosis Clin Chim Acta 214 97 101 10.1016/0009-8981(93)90306-O 1:STN:280:DyaK3s3gtFOksg%3D%3D 8453781
29. M Koter M Broncel J Chojnowska-Jezierska K Klikczynska I Franiak 2002 The effect of atorvastatin on erythrocyte membranes and serum lipids in patients with type-2 hypercholesterolemia Eur J Clin Pharmacol 58 501 506 10.1007/s00228-002-0507-9 1:CAS:528:DC%2BD38XovFyrsLY%3D 12451426 (Pubitemid 35435502)
30. AR Koudinov NV Koudinova 2005 Cholesterol homeostasis failure as a unifying cause of synaptic degeneration J Neurol Sci 229 230 233 240 10.1016/j.jns.2004.11.036 15760645 (Pubitemid 40341588)
31. J Kurantsin-Mills N Samji MA Moscarello JM Boggs 1982 Comparison of membrane structure, osmotic fragility, and morphology of multiple sclerosis and normal erythrocytes Neurol Res 7 1523 1540 1:STN:280:DyaL3s7pt1Omuw%3D%3D
32. S Kwiatkowsha G Piasecka M Zieba W Piotrowski D Nowak 1999 Increased serum concentrations of conjugated dienes and malondialdehyde in patients with pulmonary tuberculosis Respir Med 93 272 276 10.1016/S0954-6111(99)90024-0 (Pubitemid 29199607)
33. Lev N, Gilgun-Sherki Y, Offen D, Melamed E (2007) The role of oxidative stress in the pathogenesis of multiple sclerosis: current state. In: Qureshi GA, Parvez SH (eds) Oxidative stress and neurodegenerative disorders. Elsevier, New York, pp 283-295
34. Y Levy R Leibowitz M Aviram JG Brook U Cogan 1992 Reduction of plasma cholesterol by lovastatin normalizes erythrocyte membrane fluidity in patients with severe hypercholesterolaemia Br J Clin Pharmacol 34 427 430 1:STN:280:DyaK3s7gsVSiug%3D%3D 1467138
35. P Lijnen H Celis R Fagard J Staessen A Amery 1994 Influence of cholesterol lowering on plasma membrane lipids and cationic transport system J Hypertens 12 59 64 10.1097/00004872-199401000-00009 1:STN:280: DyaK2c3gvFKgtw%3D%3D 8157945
36. RL Lindberg L Achtnichts F Hoffmann J Kuhle L Kappos 2008 Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients J Neuroimmunol 194 153 164 10.1016/j.jneuroim.2007. 11.007 1:CAS:528:DC%2BD1cXjtVWnsLY%3D 18178259
37. F Lu M Selak J O'connor S Croul C Lorenzana C Butunoi B Kalman 2000 Oxidative damage to mitochondrial DNA and activity of mitochondrial enzymes in chronic active lesions of multiple sclerosis J Neurosci 177 95 103 1:CAS:528:DC%2BD3cXmt1Sjt70%3D
38. JD MacMicking DO Willenborg MJ Weidemann KA Rockett WB Cowden 1992 Elevated secretion of reactive nitrogen and oxygen intermediates in hyperacute experimental autoimmune encephalomyelitis: enhancement by the soluble products of encephalitogenic T cells J Exp Med 176 303 307 10.1084/jem.176.1.303 1:CAS:528:DyaK38XkvVymsro%3D 1319459
39. M Martinez A Vaya R Marti L Gil J Lluch R Carmena J Aznar 1996 Erythrocyte membrane cholesterol/phospholipid changes and haemorheological modifications in familial hypercholesterolemia treated with lovastatin Thromb Res 83 375 388 10.1016/0049-3848(96)00147-8 1:CAS:528:DyaK28XmtVWjurc%3D 8873346 (Pubitemid 26284111)
40. MP Mattson W Duan Z Guo 2003 Meal size and frequency affect neuronal plasticity and vulnerability to disease: cellular and molecular mechanisms J Neurochem 84 417 431 10.1046/j.1471-4159.2003.01586.x 1:CAS:528: DC%2BD3sXpvFWjtw%3D%3D 12558961 (Pubitemid 36182240)
41. S Muller O Ziegler M Donner P Drouin JF Stoltz 1990 Rheological properties and membrane fluidity of red blood cells and platelets in primary hyperlipoproteinemia Atherosclerosis 83 231 237 10.1016/0021-9150(90)90168-I 1:STN:280:DyaK3M%2FlsVKquw%3D%3D 2242099 (Pubitemid 20237881)
42. R Naidoo ML Knapp 1992 Studies of lipid peroxidation products in cerebrospinal fluid and serum in multiple sclerosis Clin Chem 38 2449 2454 1:STN:280:DyaK3s%2Fpt1aqug%3D%3D 1458583
43. X Navarro R Segura 1988 Plasma lipids and their fatty acid composition in multiple sclerosis Acta Neurol Scand 78 152 157 10.1111/j.1600-0404.1988. tb03637.x 1:STN:280:DyaL1M%2FitFyktQ%3D%3D 3176888
44. IS Nue 1983 Essential fatty acids in the serum and cerebrospinal fluid of multiple sclerosis patients Acta Neurol Scand 7 151 163
45. MR Oliveira DF Santos SB Fenelon N Penha-Silva 2007 Uso de rosuvastatina em esclerose múltipla Rev Neurosci 15 246 250
46. N Penha-Silva CB Firmino FG De Freitas Reis JCC Huss TMT De Souza MV De Freitas RCM Netto 2007 Influence of age on the stability of human erythrocyte membranes Mech Ageing Dev 128 444 449 10.1016/j.mad.2007.06.007 1:CAS:528:DC%2BD2sXovFOis7g%3D 17681589 (Pubitemid 47223380)
47. N Penha-Silva LR Arvelos CC Cunha TA Aversi-Ferreira LF Gouvêa-e-Silva MS Garrote-Filho CJ Finotti M Bernardino-Neto FG De Freitas Reis 2008 Effects of glycerol and sorbitol on the thermal dependence of the lysis of human erythrocytes by ethanol Bioelectrochemistry 73 23 29 10.1016/j.bioelechem.2008.04.002 1:CAS:528:DC%2BD1cXmvFehtL8%3D 18495554
48. C Pfafferott HJ Meiselman P Hochstein 1982 The effect of malonyldialdehyde on erythrocyte deformability Blood 59 12 15 1:CAS:528:DyaL38Xjt1ersg%3D%3D 7053759
49. RA Rabini M Polenta R Staffolani M Tocchini R Signori I Testa L Mazzanti 1993 Effect of hydroxymethylglutaryl-CoA reductase inhibitors on the functional properties of erythrocytes membranes Exp Mol Pathol 59 51 57 10.1006/exmp.1993.1026 1:STN:280:DyaK2c%2FosFGgsg%3D%3D 8262165
50. RS Rosenson CC Tangney 1998 Antiatherothrombotic properties of statins: implications for cardiovascular event reduction JAMA 279 1643 1650 10.1001/jama.279.20.1643 1:CAS:528:DyaK1cXjslyjsrY%3D 9613915 (Pubitemid 28248591)
51. CL Schauf H Frischer FA Davis 1980 Mechanical fragility of erythrocytes in multiple sclerosis Neurology 30 323 325 1:STN:280:DyaL3c7ktlGjsQ%3D%3D 7189035
52. BP Schick PK Schick 1985 Cholesterol exchange in platelets, erythrocytes and megakaryocytes BBA Lipids Lipid Metabol 833 281 290 10.1016/0005-2760(85) 90200-0 1:CAS:528:DyaL2MXhtFSmtbk%3D (Pubitemid 15140872)
53. G Schreibelt J Van Horssen S Van Rossum CD Dijkstra B Drukarch HE Vries 2007 Therapeutic potential and biological role of endogenous antioxidant enzymes in multiple sclerosis pathology Brain Res Rev 56 322 330 10.1016/j.brainresrev. 2007.07.005 1:CAS:528:DC%2BD2sXhsVSrsr%2FO 17761296 (Pubitemid 350166526)
54. S Schwarz H Leweling 2005 Multiple sclerosis and nutrition Mult Scler 11 24 32 10.1191/1352458505ms1119oa 1:CAS:528:DC%2BD2MXitFymu74%3D 15732263 (Pubitemid 40259971)
55. J Sellner I Greeve O Findling D Grandgirard SL Leib HP Mattle 2008 Atorvastatin does not alter serum levels of sCD95 and sCD95L in multiple sclerosis Clin Exp Immunol 152 280 284 1:CAS:528:DC%2BD1cXmsV2ntL4%3D 18341614
56. VKS Shukla GE Jensen J Clausen 1977 Erythrocyte glutathione peroxidase deficiency in multiple sclerosis Acta Neurol Scand 56 542 550 1:CAS:528:DyaE1cXhs1yju7k%3D 605776
57. M Sinensky 1974 Homeoviscous adaptation. A homeostatic process that regulates the viscosity of membrane lipids in Escherichia coli Proc Natl Acad Sci USA 71 522 525 10.1073/pnas.71.2.522 1:CAS:528:DyaE2cXhtlShtrk%3D 4360948
58. RL Swank O Lerstad A Strom J Backer 1952 Multiple sclerosis in rural Norway its geographic and occupational incidence in relation to nutrition N Engl J Med 246 722 728 1:STN:280:DyaG38%2FlvFCitA%3D%3D 14929306
59. X Tong N Nicolakakis P Fernandes B Ongali J Brouillette R Quirion E Hamel 2009 Simvastatin improves cerebrovascular function and counters soluble amyloid-beta, inflammation and oxidative stress in aged APP mice Neurobiol Dis 35 406 414 10.1016/j.nbd.2009.06.003 1:CAS:528:DC%2BD1MXpsFyls7w%3D 19524673
60. JJ van Doormaal WJ Bos FA Muskiet H Doorenbos 1989 Simvastatin influence linoleic acid metabolism Pharm Weekbl Sci 11 134 135 2798037
61. G van Ginkel A Sevanian 1994 Lipid peroxidation induced membrane structural alterations Methods Enzymol 233 273 288 10.1016/S0076-6879(94)33031-X 8015462
62. CJ Vaughan MB Murphy BM Buckley 1996 Statins do more than just lower cholesterol Lancet 348 1079 1082 10.1016/S0140-6736(96)05190-2 1:CAS:528:DyaK28XmvFOjurw%3D 8874463 (Pubitemid 26343606)
63. O Vladimirova FM Lu L Shawver B Kalman 1999 The activation of protein kinase C induces higher production of reactive oxygen species by mononuclear cells in patients with multiple sclerosis than in controls Inflamm Res 48 412 416 10.1007/s000110050480 1:CAS:528:DyaK1MXks1Gkurs%3D 10450792 (Pubitemid 29361251)
64. CL White PJ Pistell MN Purpera S Gupta S Fernandez-Kim TL Hise JN Keller DK Ingram CD Morrison AJ Bruce-Keller 2009 Effects of high fat diet on Morris maze performance, oxidative stress, and inflammation in rats: contributions of maternal diet Neurobiol Dis 35 3 13 10.1016/j.nbd.2009.04.002 1:CAS:528:DC%2BD1MXntVyrurs%3D 19374947